In the present study, we found that low TET1 expression was strongly associated with better patient survival in different cancers, including thyroid cancer, consistent with in vivo results that Tet1 knockout in transgenic mouse model of thyroid cancer suppressed tumor progression and prolonged mice survival. This evidence concerns the gene TET1 and neoplasm.